Blog / Archives
Immuno-Oncology: New Products Provide Growth and Value: ABBV BMY
Immuno-Oncology: Sweet Spot in a Biotech Bear Market We will continue to track large cap biopharma Q1 earnings looking for value+growth ideas. The financial metrics will be tracked as we did in our...
Biotech Bear Market: Can Diversified Healthcare Funds Beat ETFS?…Part-1
Biotech Bear Market: XLV ---A Large Cap Healthcare ETF Outperforms We have compared the performance of top mutual funds in the past and thought it would be interesting to see what happens in a bear...
Biotech Recovery Rally: Steady as She Goes-Biogen Rallies on Earnings…Update-1
Expect Modest Rally in Biotechs Through Q1 Earnings As of mid-day trading 1P EDT with flat NASDAQ Update at close: biotechs held onto gains despite a mild sell-off for the Dow and S&P with...
Rayno Biopharmaceuticals 2016 Update: 4/14 All In the Green!
Rayno Biopharmaceutical Picks For 2016 Focus is larger cap stocks that pay dividends with one speculative pick (BLUE). XBI is a potential trade for momentum but the IBB can be used for larger cap...
Biotech Rally Fizzles: Needs Help from M&A
Biotech Rally Loses Momentum But Still Up for the Week IBB up 3.37 % , XBI up 5.04% , XLV up 0.77% this week. Investors took profits today despite all of the media focus and renewed excitement for...
Healthcare Stocks Lead on a Lackluster Day…Update-1… Biotech Rally Continues
Update 4/6/16 Biotech Rally Picks Up Momentum Today IBB up 4.5%,XBI up 5% Speculative stocks lead the way: BLUE up 10%, VRX up 16.6% --------Risk on mode continues--------- Healthcare Sector Leads...
Rayno Biopharmaceuticals: New Buy Idea- Roche plc (RHBBY)
Roche/Genentech Has a Strong Pipeline in Diagnostics and Therapeutics to Drive Moderate Growth in 2016 New Stock Pick: Roche Holding (OTCQX:RHHBY) $30.36 Over the past 3 months we recommended...
Rayno Biopharmaceuticals Update 3/30-Stuck in a Trading Range with Upside Opportunities
Rayno Biopharmaceutical Portfolio Update- Biotechs with Upside Opportunity Caution No Rush to "Load Up" in a Bear Market Since Mid-January all of our previous portfolios were placed on hold and we...
Busted Biotechs Week ending 3/18/16: The Only Good News Could Be Holding the February Bottom…Update 3/22
3/22/16...Update Biotech Rally Enters Fourth Day-Green Screen XBI up 7.34% Over Five Days to $52.49 Our new picks were up today: ABBV,BLUE, BMY,GILD. But Gilead Sciences (GILD) was down after hours...
Monday Movers in the Biotech Bear Market…ALNY, GILD, GWPH
Tuesday 12:45pm EDT Update on a red screen day: Healthcare sector lags down 1.6%, biotechs now being crushed IBB down 3.1%,XBI down 5%! -------- Look for Value +Growth Picks in a Biotech Bear Market...